Science
Mechanism of Action
Functions as a competitive inhibitor of tyrosinase, the key enzyme controlling melanin production, specifically blocking the conversion of L-DOPA to melanin. Simultaneously provides antioxidant activity that neutralizes free radicals from UV exposure, addressing both primary and secondary pathways of pigmentation formation.
Research
Clinical Evidence
Medium confidence0.5%
Key findings
- 01 At 0.5% concentration, in-vivo testing showed significant hyperpigmentation reduction and enhanced skin radiance, outperforming 1% kojic acid
- 02 Demonstrated superior tyrosinase inhibition in human melanocyte cultures compared to arbutin across 0.1-0.5% range
Transparency
Dusting Analysis
Effective concentrations start at 0.1% with optimal results at 0.5%, making dusting unlikely to provide meaningful brightening benefits
The Formula
Formulation
Stability
Extremely light and oxidation sensitive, prone to yellow/brown discoloration when exposed to air. Requires opaque, airless packaging and stabilization with chelating agents or antioxidants.
Synergies
- EDTA (chelating)
- Vitamin E (antioxidant stabilization)
Conflicts
- Strong oxidizing agents
- Alkaline pH environments above 7.0
- Iron-containing ingredients
Safety
Safety Profile
Approved in China and EU markets with 0.5% concentration limits for leave-on products due to potential sensitization at higher levels
Your Skin
Skin Compatibility
Our Assessment
Verdict
A potent, clinically-backed brightening agent that outperforms traditional alternatives, though formulation complexity and sensitivity concerns limit broader accessibility.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources